<- Go Home

Innovotech Inc.

Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assay lids; and order biofilm assays. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices testing; bacteriophage testing; and analytical services. The company serves customers in the sector of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food. Innovotech Inc. is headquartered in Edmonton, Canada.

Market Cap

CAD 4.4M

Volume

38.2K

Cash and Equivalents

CAD 374.7K

EBITDA

-CAD 635.5K

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

CAD 1.5M

Profit Margin

39.39%

52 Week High

CAD 0.29

52 Week Low

CAD 0.07

Dividend

N/A

Price / Book Value

N/A

Price / Earnings

N/A

Price / Tangible Book Value

N/A

Enterprise Value

CAD 4.2M

Enterprise Value / EBITDA

-6.60

Operating Income

-CAD 803.4K

Return on Equity

31.31%

Return on Assets

-14.81

Cash and Short Term Investments

CAD 374.7K

Debt

CAD 163.3K

Equity

CAD 2.6M

Revenue

CAD 3.7M

Unlevered FCF

-CAD 1.3M

Sector

Life Sciences Tools and Services

Category

N/A

Company Stock Pitches